Latest News and Press Releases
Want to stay updated on the latest news?
-
Avance Clinical is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate drug development programs.
-
The Global Virus Network believes that systemic inadequacies and vulnerabilities persist, which threaten public health on a global scale.
-
GVN calls on world governments to address the threat of H5N1 avian influenza by enhancing surveillance, implementing biosecurity measures, and preparing
-
Dr. Rietiker has considerable experience in the life sciences industry, including leadership positions in global pharmaceutical and medical device companies, and has overseen multiple major company...
-
Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience in the biotech and pharmaceutical industry, especially in research and...
-
Congress will take place April 21-24, 2025, in Washington, D.C.COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in...
-
Wilmington, Delaware, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Vaccine Adjuvants Market by Type (Immunostimulants, Vehicles and Mucosal Adjuvants),...
-
60 Degrees Pharma (SXTP) announces a $1.075M registered direct offering, issuing stock and warrants to fund working capital and corporate initiatives.
-
New York, United States, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Viruses including influenza, mumps, measles, and hepatitis can be among the world's deadliest killers. Researchers from all around the...
-
Agreement provides MSD with options to license Evaxion’s preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on...